Antibacterials in the pipeline and perspectives for the near future

Ian M Gould; Chathuri Gunasekera; Ali Khan

doi:10.1016/j.coph.2019.05.001

Antibacterials in the pipeline and perspectives for the near future

Curr Opin Pharmacol. 2019 Oct:48:69-75. doi: 10.1016/j.coph.2019.05.001. Epub 2019 Jun 11.

Authors

Ian M Gould¹, Chathuri Gunasekera², Ali Khan³

Affiliations

¹ Aberdeen Royal Infirmary, Foresterhill, Aberdeen, AB25 2ZN, United Kingdom; University of Aberdeen, Aberdeen, United Kingdom.
² Aberdeen Royal Infirmary, Foresterhill, Aberdeen, AB25 2ZN, United Kingdom; University of Colombo, Colombo, Sri Lanka. Electronic address: chathuri.gunasekera@nhs.net.
³ Aberdeen Royal Infirmary, Foresterhill, Aberdeen, AB25 2ZN, United Kingdom.

PMID: 31200170
DOI: 10.1016/j.coph.2019.05.001

Abstract

Antimicrobial resistance is a global threat to the management of infections in our patients. Sound stewardship of antibacterial agents at our disposal must be accompanied by a concerted effort to develop new agents to bolster our armamentarium. This review will cover the latest antibiotics that have come through the pipeline and the role they can play in the management of infections that are increasingly difficult to treat due to resistance mechanisms.

Publication types

Review

MeSH terms

Animals
Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use*
Humans

Substances

Anti-Bacterial Agents